Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

NCT00930644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: teduglutide

Sponsor

Shire

Collaborators

[object Object]